Have a personal or library account? Click to login
Erythromycin or Clindamycin – is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin? Cover

Erythromycin or Clindamycin – is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin?

Open Access
|Jun 2017

Abstract

Retrospective analysis of Streptococcus agalactiae antibiotic susceptibility isolated in 2010–2013 was performed. Penicillin was still the firstline antibiotic. Due to the high percentage of strains resistant to erythromycin and clindamycin empirical treatment with these antibiotics may not be effective. Lower resistance rate to erythromycin and clindamycin among strains isolated from infected pregnant women and newborns were observed than among strains isolated from samples from patients hospitalized in other departments (29% and 47% v. 46% and 63%). The increasing resistance rate might give a rise to a new epidemiological situation.

DOI: https://doi.org/10.5604/01.3001.0010.7878 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 265 - 268
Submitted on: Aug 11, 2016
Accepted on: Jan 27, 2017
Published on: Jun 28, 2017
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 PIOTR LESZCZYŃSKI, BEATA SOKÓŁ-LESZCZYŃSKA, BRONISŁAWA PIETRZAK, ANNA SAWICKA-GRZELAK, MIROSŁAW WIELGOŚ, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.